Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - lerkanidipin - filmsko obložena tableta - lerkanidipin 9,4 mg / 1 tableta - lerkanidipin

Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - lerkanidipin - filmsko obložena tableta - lerkanidipin 18,8 mg / 1 tableta - lerkanidipin

Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - lerkanidipin - filmsko obložena tableta - lerkanidipin 9,4 mg / 1 tableta - lerkanidipin

Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - lerkanidipin - filmsko obložena tableta - lerkanidipin 18,8 mg / 1 tableta - lerkanidipin

Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ebewe pharma - folinska kislina - kapsula, trda - folinska kislina 15 mg / 1 tableta - kalcijev folinat

Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ebewe pharma - folinska kislina - kapsula, trda - folinska kislina 15 mg / 1 tabletakalcijev folinat pentahidrat - kalcijev folinat

Europska Unija - slovenski - EMA (European Medicines Agency)

teva generics b.v - monohidrat zoledronske kisline - osteoporosis; osteitis deformans - bisfosfonati - zdravljenje osteoporosisin post-menopavzi womenin odraslih menat povečano tveganje za zlome, vključno s tistimi z zadnjih nizko travme, zlom kolka. zdravljenje osteoporoze, povezane z dolgoročno sistemsko glukokortikoidnih therapyin post-menopavzi womenin odraslih menat povečano tveganje za zlome. zdravljenje paget je bolezen kosti v odrasli.

Europska Unija - slovenski - EMA (European Medicines Agency)

teva b.v. - zoledronska kislina - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - zdravila za zdravljenje bolezni kosti - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. zdravljenje paget je bolezen kosti v odrasli.

Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

splendris pharmaceuticals gmbh - klopidogrel - filmsko obložena tableta - klopidogrel 75 mg / 1 tableta - klopidogrel

Europska Unija - slovenski - EMA (European Medicines Agency)

viatris limited - klopidogrel besilat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotična sredstva - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segmentu višinskih akutni miokardni infarkt, v kombinaciji s asa v medicinsko zdravljenih bolnikih, ki izpolnjujejo pogoje za thrombolytic terapija. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. za nadaljnje informacije, prosimo, preberite razdelek 5.